Anthracycline-based combination chemotherapy (Doxorubicin and Dacarbazine) for the desmoid tumor in a neoadjuvant setting. Report of a case
<p>We report a case of a 41-years-old female with a sporadic abdominal wall desmoid tumor. After a period of 12-months observation, chemotherapy was given with Doxorubicin and Dacarbazine to facilitate minimal surgery. The patient received 4 cycles of chemotherapy. Treatment was well tolerated...
Saved in:
Main Authors: | Mahmood S (Author), Divyanshu Dua (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2021-04-26.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012) -
Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
Published: (2013) -
Effects of Neoadjuvant Chemotherapy and Radiotherapy on Flap Perfusion in a Novel Mouse Model Using Standard Clinical Assessment and Near-Infrared Fluorescence Angiography
by: Tushar Ramesh, et al.
Published: (2017) -
Essentially new inhibitors of metastasis of malignant tumors for chemotherapy-sparing treatment
by: ISh Nadiradze, et al.
Published: (2021) -
Novel insights on use of doxorubicin to treat chemoresistant TNBC by Immunotherapy
by: Tze-Chen Hsieh, et al.
Published: (2020)